Bio Rad Laboratories Inc
BIOb300.500USD
-4.970-1.63%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
8.11BMarket Cap
LossP/E TTM
More Details of Bio Rad Laboratories Inc Company
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Bio Rad Laboratories Inc Info
Ticker SymbolBIOb
Company nameBio Rad Laboratories Inc
IPO dateMar 17, 1980
CEOSchwartz (Norman D)
Number of employees7700
Security typeOrdinary Share
Fiscal year-endMar 17
Address1000 Alfred Nobel Dr
CityHERCULES
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code94547
Phone15107247000
Websitehttps://www.bio-rad.com/
Ticker SymbolBIOb
IPO dateMar 17, 1980
CEOSchwartz (Norman D)
Company Executives of Bio Rad Laboratories Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
431.47K
+15.22%
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
Mr. Jonathan P. (Jon) Divincenzo
Mr. Jonathan P. (Jon) Divincenzo
President, Chief Operating Officer
President, Chief Operating Officer
--
--
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
--
--
Mr. Jeffrey L. (Jeff) Edwards
Mr. Jeffrey L. (Jeff) Edwards
Independent Director
Independent Director
--
--
Mr. Roop K. Lakkaraju
Mr. Roop K. Lakkaraju
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
--
--
Mr. Arnold A. Pinkston
Mr. Arnold A. Pinkston
Independent Director
Independent Director
--
--
Mr. Edward Chung
Mr. Edward Chung
Vice President - Investor Relations
Vice President - Investor Relations
--
--
Mr. James J. Barry
Mr. James J. Barry
Executive Vice President, President - Life Science Group
Executive Vice President, President - Life Science Group
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
431.47K
+15.22%
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
Mr. Jonathan P. (Jon) Divincenzo
Mr. Jonathan P. (Jon) Divincenzo
President, Chief Operating Officer
President, Chief Operating Officer
--
--
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
--
--
Mr. Jeffrey L. (Jeff) Edwards
Mr. Jeffrey L. (Jeff) Edwards
Independent Director
Independent Director
--
--
Mr. Roop K. Lakkaraju
Mr. Roop K. Lakkaraju
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
266.90M
40.96%
Europe
217.20M
33.33%
APAC
126.40M
19.40%
Other
41.10M
6.31%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Wed, Apr 2
Updated: Wed, Apr 2
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Blue Raven Partners, L.P.
80.10%
Alice N. Schwartz Revocable Trust
8.63%
Schwartz (Norman D)
8.51%
Schwartz (Steven D)
0.75%
Allison (Schwartz)
0.08%
Other
1.92%
Shareholders
Shareholders
Proportion
Blue Raven Partners, L.P.
80.10%
Alice N. Schwartz Revocable Trust
8.63%
Schwartz (Norman D)
8.51%
Schwartz (Steven D)
0.75%
Allison (Schwartz)
0.08%
Other
1.92%
Shareholder Types
Shareholders
Proportion
Corporation
88.74%
Individual Investor
9.35%
Investment Advisor
0.07%
Other
1.85%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
13
3.80K
0.06%
--
2025Q3
15
3.80K
0.10%
+757.00
2025Q2
15
3.05K
0.12%
+2.00
2025Q1
18
3.04K
0.13%
-3.56K
2024Q4
18
4.22K
0.13%
-23.00
2024Q3
17
4.24K
0.12%
+647.00
2024Q2
18
3.60K
0.13%
-211.00
2024Q1
19
3.81K
0.15%
-3.64K
2023Q4
20
3.78K
2.06%
-1.99K
2023Q3
20
5.76K
2.06%
+2.00
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Blue Raven Partners, L.P.
4.06M
80.08%
--
--
May 01, 2025
Alice N. Schwartz Revocable Trust
437.51K
8.63%
--
--
May 01, 2025
Schwartz (Norman D)
374.47K
7.39%
+114.00
+0.03%
Feb 24, 2025
Schwartz (Steven D)
38.24K
0.75%
+57.00
+0.15%
Feb 24, 2025
Allison (Schwartz)
4.00K
0.08%
+57.00
+1.45%
Feb 24, 2025
CSS, LLC
1.09K
0.02%
--
--
Jun 30, 2025
Focus Partners Wealth, LLC
--
0%
-760.00
-100.00%
Mar 31, 2025
Buckingham Strategic Wealth, LLC
760.00
0.01%
--
--
Jun 30, 2024
Morgan Stanley Smith Barney LLC
692.00
0.01%
--
--
Jun 30, 2025
Wells Fargo Advisors
170.00
0%
--
--
Jun 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Bio Rad Laboratories Inc?
The top five shareholders of Bio Rad Laboratories Inc are:
Blue Raven Partners, L.P. holds 4.06M shares, accounting for 80.08% of the total shares.
Alice N. Schwartz Revocable Trust holds 437.51K shares, accounting for 8.63% of the total shares.
Schwartz (Norman D) holds 374.47K shares, accounting for 7.39% of the total shares.
Schwartz (Steven D) holds 38.24K shares, accounting for 0.75% of the total shares.
Allison (Schwartz) holds 4.00K shares, accounting for 0.08% of the total shares.
Blue Raven Partners, L.P. holds 4.06M shares, accounting for 80.08% of the total shares.
Alice N. Schwartz Revocable Trust holds 437.51K shares, accounting for 8.63% of the total shares.
Schwartz (Norman D) holds 374.47K shares, accounting for 7.39% of the total shares.
Schwartz (Steven D) holds 38.24K shares, accounting for 0.75% of the total shares.
Allison (Schwartz) holds 4.00K shares, accounting for 0.08% of the total shares.
What are the top three shareholder types of Bio Rad Laboratories Inc?
The top three shareholder types of Bio Rad Laboratories Inc are:
Blue Raven Partners, L.P.
Alice N. Schwartz Revocable Trust
Schwartz (Norman D)
Blue Raven Partners, L.P.
Alice N. Schwartz Revocable Trust
Schwartz (Norman D)
How many institutions hold shares of Bio Rad Laboratories Inc (BIOb)?
As of 2025Q4, 13 institutions hold shares of Bio Rad Laboratories Inc, with a combined market value of approximately 3.80K, accounting for 0.06% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -0.04%.
What is the biggest source of revenue for Bio Rad Laboratories Inc?
In FY2025Q2, the -- business generated the highest revenue for Bio Rad Laboratories Inc, amounting to -- and accounting for --% of total revenue.
